BMS’ Opdivo and Yervoy combination shows outstanding survival rate in cancer patients
October 22, 2018Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, Yervoy, melanoma, opdivo
American pharma firm Bristol-Myers Squibb have announced that more than 53% of patients with advanced melanoma, who were treated with …
GSK named third best UK workplace
October 22, 2018Sales and Marketing AbbVie, Amgen, BMS, Eli Lilly, GSK, J&J, JJ, work
British multinational GlaxoSmithKline has been rated as the third best company to work for in the UK, according to jobs …
MSD’s Keytruda with Pfizer’s Inlyta beats Sutent in most common kidney cancer
October 19, 2018Medical Communications, Research and Development Cancer, Kidney cancer, MSD, Pfizer, inlyta, keytruda, pharma
MSD has unveiled new Phase 3 data on its blockbuster anti-PD-1 cancer therapy Keytruda (pembrolizumab) as part of a combination, …
Top Ten most popular articles on Pharmafile.com this week
October 19, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, AstraZeneca, Bayer, Novartis, Samsung, Trump, biosimilars, brexit
Business, biosimilars and Brexit are the themes of this week’s top 10. While Roche signed a $1 billion deal with …
US FDA offers plan for global regulatory harmonisation for generic drugs
October 19, 2018Medical Communications FDA, ICH, generic drugs, harmonisation, regulatory bodies
The US Food and Drug Administration (FDA) is offering a proposal to the International Council on Harmonisation (ICH) aimed at …
NICE rejects Elil Lilly’s Verzenio for breast cancer in draft guidance
October 19, 2018Medical Communications, Sales and Marketing Eli Lilly, NICE, UK, Verzenios, breast cancer, pharma
Eli Lilly and patients with breast cancer patients in the UK have been dealt a blow as NICE confirmed that …
MSF warns of antibiotic resistance crisis in Gaza
October 19, 2018Medical Communications AMR, Gaza, MSF, Palestine, antibiotic resistance, israel
The international non-governmental organisation (NGO) Médecins Sans Frontières (MSF) has warned that antibiotic resistant infections are a “certainty” in Gaza. …
Robot addresses British MPs over future of AI
October 18, 2018Medical Communications AI, Robot, UK, artificial intelligence, british parliament
British MPs questioned the first robot to ever attend a UK parliamentary meeting this month, after a robot called Pepper …
Hearing loss and inner ear disorders: The next frontier for pharmaceutical success?
October 18, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sensorion, hearing loss, inner ear disorders, opinion, pharma
Nawal Ouzren, CEO of Sensorion, examines the latest therapies and developments emerging in the difficult-to-treat world of human ear disorders, …
GSK to axe 99 positions at Memphis site
October 18, 2018Manufacturing and Production GSK, US, pharma
GlaxoSmithKline’s workforce on President’s Island in Memphis, US, is set to see the loss of 99 employees, as revealed in …
Novartis snaps up cancer drug developer Endocyte for $2.1 billion
October 18, 2018Research and Development, Sales and Marketing Cancer, Endocyte, Novartis, pharma
Novartis will shell out $2.1 billion to acquire cancer drug developer Endocyte in a move to leverage the company’s technology …
MHRA to extend EpiPen expiry dates to tackle shortages
October 18, 2018Manufacturing and Production, Sales and Marketing ALK+, Denmark, Mylan, UK, alk, epipen
The British government has extended the expiry date on epinephrine pens amid a shortage in the UK. The Danish pharmaceutical …
Pfizer announce cull of 2% of staff
October 18, 2018Business Services, Medical Communications, Sales and Marketing Bourla, Ian Read, Jobs, Pfizer, america, layoffs
US pharma giant Pfizer is offering early retirement to American workers ahead of layoffs scheduled for next year. The company …
Researchers launch Phase 1 trial of HIV vaccine
October 18, 2018Research and Development AIDS, HIV, Vaccine, infection, resdearch
Researchers working with the non-profit organisation the International AIDS Vaccine Initiative (IAVI) have announced the launch of a Phase I …
Samsung and Bioepis launch third Humira biosimilar in Europe
October 17, 2018Research and Development, Sales and Marketing Amgen, Biogen, Humira, Imraldi, Samusng Bioepis, pharma
Hot on the heels of Amgen, Samsung Bioepis and Biogen have announced the launch of their own biosimilar version of …
Roche signs $1 billion deal with cell therapy firm SQZ biotech
October 17, 2018Research and Development Roche, SQZ, collaboration, deal, oncology
The Massachusetts-based cell therapy company SQZ Biotech, has announced the expansion of its collaboration with Swiss pharma giant Roche, in …
Fewer patents being filed for novel infectious diseases and AMR diagnostic technologies; US leads, UK follows
October 17, 2018Research and Development AMR, IP, intellectual property, patents
Fewer patents are being filed for point-of-care diagnostic technologies aimed at tackling infectious diseases and antimicrobial resistance (AMR), according to …
FDA approves Pfizer’s Talzenna for breast cancer alongside tool to identify eligible patients
October 17, 2018Research and Development, Sales and Marketing Cancer, FDA, Pfizer, Talzenna, breast cancer, pharma
Pfizer’s Talzenna (talazoparib) has secured FDA approval, it has emerged. The poly (ADP-ribose) polymerase (PARP) inhibitor is now set to …
Prescription painkillers reclassified amid addiction concerns
October 17, 2018Research and Development UK, addiction, classification, painkillers, policy
Two commonly prescribed painkillers are set to be put under tighter controls in the United Kingdom after a number of …
Roche’s Kadcyla beats Herceptin breast cancer disease recurrence and death risk
October 16, 2018Manufacturing and Production, Sales and Marketing Cancer, Kadcyla, Roche, breast cancer, pharma
Roche has unveiled new data for its antibody-drug conjugate Kadcyla (trastuzumab emtansine) in the treatment of patients with HER2-positive early …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
